SOME ASPECTS OF THE MUKOAKTIV THERAPY OF ACUTE RESPIRATORY DISEASES IN THE CHILDREN

2013 ◽  
Vol 4 (3) ◽  
pp. 61-64
Author(s):  
Natalya Dmitriyevna Soroka
Keyword(s):  
Clinical Characteristics ◽  
Respiratory Diseases ◽  
Sick Child ◽  
Respiratory Infections ◽  
Early Age ◽  
Efficacy And Safety ◽  
Acute Respiratory Disease ◽  
Dry Extract ◽  
Post Marketing ◽  
Acute Respiratory Diseases

The article presents the data on acute respiratory infections in children, defined the characteristics of the modern trends, gives a brief clinical characteristics of protracted variants of acute respiratory disease. The reasonability of mykoaktive therapy in the treatment of acute respiratory diseases. Presents data post marketing study of efficacy and safety of mykoaktive preparation Prospan (Manufacturer Engelhard Arzneimittel, Germany). Prospan marked by a high secretolytic, bronchospasmolytic effects and safety of dry extract of leaves of ivy of the treatment of acute respiratory diseases, including children of early age, as well as the opportunity to personalize the application of various medicinal forms preparation and ways of delivery to the organism of a sick child.

scholarly journals Efficacy and safety of dry extract of ivy leaves in therapy of respiratory diseases in children

2008 ◽  
pp. 86-92
Author(s):  
N. D. Soroka ◽  
S. P. Gomozova ◽  
I. V. Ilyina ◽  
E. A. Krechmar ◽  
E. A. Antonova ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Safety Profile ◽  
Respiratory Diseases ◽  
Early Age ◽  
Efficacy And Safety ◽  
Wide Spread ◽  
Dry Extract ◽  
Good Safety Profile ◽  
Post Marketing

Data of morbidity of respiratory diseases in children at Sankt-Petersburg are given in the article. The authors described significance and current features of respiratory diseases in children, showed a role of mucostasis in poor course and importance of mucoactive therapy in community-acquired and in-hospital respiratory pathologies. Results of post-marketing clinical trial of mucoactive efficacy of Prospan in 180 children of 6 months to 17 years of age with wide-spread respiratory diseases have been presented in the article. High mucolytic and bronchodilating activity and good safety profile of Prospan, which is dry extract of ivy leaves, have been demonstrated. No interaction was noted between Prospan and other medications used in the treatment of respiratory diseases in children. Therapy with dry extract of ivy leaves was safe in children with most prevalent co-existing pathology including early age children.

scholarly journals Fenspiride use in acute respiratory infections in children

2019 ◽  
pp. 120-123
Author(s):  
N. G. Kolosova ◽  
M. D. Shakhnazarova
Keyword(s):  
Safety Profile ◽  
Respiratory Diseases ◽  
Respiratory Infections ◽  
Economic Problem ◽  
Acute Respiratory Infections ◽  
Efficacy And Safety ◽  
High Efficacy ◽  
Acute Respiratory Diseases ◽  
Anti Inflammatory

Acute respiratory infections are the most common pathology in childhood, representing not only a medical but also a socio-economic problem. Numerous studies on the use of anti-inflammatory therapy in ARI have shown high efficacy and safety profile of fenspiride. The combination of anti-inflammatory, antiallergic, and antispasmodic properties ensures the success of fenspiride in the treatment of acute respiratory diseases in children. Fenspiride reduces symptoms of ARI, accelerates recovery, reduces the need for additional prescription of other drugs.

scholarly journals Treatment of respiratory diseases with inhalation patches

2019 ◽  
pp. 89-94
Author(s):  
L S. Starostina
Keyword(s):  
Adverse Events ◽  
Respiratory Tract ◽  
Risk Reduction ◽  
Mucous Membrane ◽  
Respiratory Diseases ◽  
Respiratory Infections ◽  
Early Age ◽  
Ciliated Epithelium ◽  
Constant Attention ◽  
High Incidence

The high incidence of respiratory infections at an early age requires constant attention of doctors of various specialties. It should be born in mind that the development of the respiratory tract in young children has unique features, and that different drugs can have different effects on the mucous membrane and ciliated epithelium. Also take into account the possibility of using different ways drugs can be administered to prevent and treat respiratory infections with due account for the age of the child, the effectiveness of action and adverse events risk reduction.

scholarly journals Etiological characteristics of acute respiratory diseases in servicemen of the Western military district in 2014-2019

2020 ◽  
Vol 22 (1) ◽  
pp. 81-86
Author(s):  
A N Gorenchuk ◽  
P V Kulikov ◽  
S D Zhogolev ◽  
R M Aminev ◽  
A A Kuzin ◽  
...  
Keyword(s):  
Environmental Sustainability ◽  
Respiratory Diseases ◽  
Respiratory Infections ◽  
Genetic Material ◽  
Influenza Viruses ◽  
Respiratory Pathogens ◽  
Acute Respiratory Diseases ◽  
Socio Demographic Factors ◽  
Comparison Of The Results ◽  
Active Implementation

The species affiliation of respiratory pathogens isolated from patients and carriers in the military units of the Western Military District in 2014-2019 was studied. The analysis of long-term and seasonal dynamics of their circulation is carried out. It was found that S. pneumoniae and adenoviruses are more often detected in acute respiratory diseases in conscripts. The genetic material of adenoviruses was found in 31,9% of samples, influenza viruses in 13,3%, rhinoviruses in 11,2%, respiratory syncytial viruses in 1,7%, metapneumoviruses in 0,9%, parainfluenza viruses 0,7%, bocaviruses0,5%, coronaviruses 0,1%, S. pneumoniae 33,9%, H. influenzae 13%, M. pneumoniae 9%, C. pneumoniae - in 3,3%, N. meningitidis - in 16%. Comparison of the results of work with studies carried out by domestic research groups among the civilian population in the same period showed that the circulation of various respiratory viruses depends on the year, season, and is also influenced by socio-demographic factors. A direct high functional correlation was found between the dynamics of circulation of adenovirus and S. pneumoniae in different years and epidemic seasons. Evidence has been obtained of the active implementation of the process of self-maintenance of the reservoir of infections and the multifactorial nature of the overall environmental sustainability of the system in organized military teams. In the etiological structure of respiratory infections, the proportion of pathogens varies depending on the season in different years, the characteristics of the formation and composition of organized groups, as well as epidemic periods.

scholarly journals EFFECTIVENESS OF FIXED COMBINATION OF FORMULATIONS FOR COUGHING

2020 ◽  
Vol 20 (4) ◽  
pp. 45-48
Author(s):  
V. M. Zhdan ◽  
Н. S. Khaimenova ◽  
M. Yu. Babanina ◽  
O.A. Kyrian ◽  
I. V. Ivanitskiy
Keyword(s):  
Respiratory Disease ◽  
Respiratory Diseases ◽  
Comparison Group ◽  
Clinical Symptoms ◽  
Fixed Combination ◽  
Pathological Process ◽  
Efficacy And Safety ◽  
Bronchial Secretion ◽  
Acute Respiratory Diseases ◽  
The Difference

There are many respiratory diseases, which despite the difference in aetiology, pathogenesis, the peculiarities in progression may have some common features, resulting in the localization of the pathological process in the respiratory systems. These common signs include changes in bronchial secretion that ultimately leads to mucostasis and burdens the course of any respiratory disease. There are very few combined formulations capable of impacting several mechanisms of mucostasis at once. One of them is Ascoril possessing a double effect of bronchodilator and expectorant. The aim of this study was to evaluate the clinical efficacy and safety of Ascoril therapy for patients with acute respiratory diseases. The study included 105 patients aged 25 ± 0.5 to 55 ± 1.6 years with mild or moderate acute respiratory disease, who had acute respiratory diseases with cough due to laryngitis, pharyngitis, tracheitis, bronchitis. Patients of the 1st group (75 patients, the main group) received the treatment with Ascoril, the patients of the 2nd group (30 patients, the comparison group) received Bromhexine. The patients in both groups were comparable by age and sex. The patients treated with Ascoril showed the disappearance of cough symptoms 3 – 4 days earlier than the patients in the comparison group (p < 0.05). The total score assessment of clinical symptoms during the treatment demonstrated the administration of Ascoril promoted the effectiveness of therapy, which was found significantly higher than in the 2nd group (p < 0.05). We can conclude Ascoril reduces the duration of the disease, cut down the need in antibiotics, lowers the manifestations of bronchial hyper reactivity, and promotes faster clinical recovery, the last but not the least, it is safe.

Halotherapy in the rehabilitation of children in educational institutions

2020 ◽  
pp. 30-36
Author(s):  
Maya Khan ◽  
Irina Ivanova ◽  
Natalya Mikitchenko ◽  
Anna Dedurina ◽  
Natalya Lyan
Keyword(s):  
Respiratory Disease ◽  
Therapeutic Effect ◽  
Respiratory Diseases ◽  
Educational Institutions ◽  
Optimal Parameters ◽  
Acute Respiratory Disease ◽  
Acute Respiratory Diseases ◽  
Anti Inflammatory ◽  
The Impact

The aim of the study was to assess the impact of halotherapy performed in halocabinets on the health of children who often suffer from acute respiratory diseases. Based on the data obtained, the pronounced anti-inflammatory and sanogenetic effect of the factor was established, and the optimal parameters and halotherapy regimens were determined depending on the presence of symptoms of acute respiratory disease. Follow-up observations have confirmed the durability of the therapeutic effect.

Newer Virus Diseases: Clinical Differentiation of Acute Respiratory Infections

PEDIATRICS ◽  
1961 ◽  
Vol 27 (1) ◽  
pp. 44-44
Author(s):  
DAVID T. KARZON
Keyword(s):  
Respiratory Diseases ◽  
Small Volume ◽  
Respiratory Infections ◽  
Daily Practice ◽  
Clinical Aspects ◽  
Acute Respiratory Infections ◽  
Viral Etiology ◽  
Virus Diseases ◽  
Acute Respiratory Diseases ◽  
Basic Concepts

Acute respiratory diseases, especially those of viral etiology, occupy a goodly proportion of the attention of the pediatrician in his daily practice. In this small volume, Dr. Adams attempts to bring together the rapidly appearing information regarding recent discoveries and innovations in virology and correlate them with clinical aspects of respiratory infection. Sections are devoted to introducing basic concepts in virology and to anatomic and physiologic aspects of the respiratory system in relation to infection.

scholarly journals Clinical Experience in Germany of Treating Community-Acquired Respiratory Infections with the New 8-Methoxyfluoroquinolone, Moxifloxacin

2001 ◽  
Vol 29 (2) ◽  
pp. 51-60 ◽  
Author(s):  
H Landen ◽  
M Möller ◽  
GS Tillotson ◽  
R Kubin ◽  
G Höffken
Keyword(s):  
Adverse Drug Reaction ◽  
Drug Reaction ◽  
Clinical Practice ◽  
Bacterial Pneumonia ◽  
Respiratory Infections ◽  
Symptom Relief ◽  
Efficacy And Safety ◽  
Community Based ◽  
Acute Exacerbations ◽  
Post Marketing

Moxifloxacin, a new 8-methoxyfluoroquinolone, was evaluated in a large community-based study involving 16 007 patients over a 9-month period. This study was designed as a large post-marketing observational study of the speed, efficacy and tolerability of moxifloxacin when used in clinical practice for the treatment of community-acquired bacterial pneumonia, or acute exacerbations of chronic bronchitis. Physicians and patients were specifically questioned about overall efficacy and safety as well as symptom relief. According to physicians' assessments 96.3% of patients were cured or improved after moxifloxacin treatment. Symptom relief (‘feeling better’) occurred in almost 70% of patients by day 3 and only 2.3% reported an adverse drug reaction. No individual adverse drug reaction was reported at a frequency above 1%. Among the 209 events considered as serious, only 34 were regarded as possibly or probably related to therapy. There were no moxifloxacin-related clinically relevant cases of phototoxicity, hepatotoxicity or cardiotoxicity. Overall, 92.1% of patients considered moxifloxacin to have been beneficial.

Nursing patients with respiratory problems

2009 ◽  
pp. 99-134
Keyword(s):  
Respiratory Disease ◽  
Respiratory Diseases ◽  
Oxygen Therapy ◽  
Respiratory Infections ◽  
Acute Respiratory Disease ◽  
Nursing Assessment ◽  
Surgical Interventions ◽  
Chronic Respiratory Diseases ◽  
Respiratory Problems

Nursing assessment of patients with respiratory problems 100 Common respiratory nursing problems 102 Oxygen therapy 104 Tests and investigations 108 Respiratory infections 110 Chronic respiratory diseases: innate 112 Chronic respiratory diseases: acquired 114 Acute respiratory disease 118 Common respiratory surgical interventions 120 Respiratory equipment 122...

scholarly journals Acute respiratory diseases: progression features, pharmaceutical therapy

2018 ◽  
pp. 82-88
Author(s):  
N. V. Orlova ◽  
T. G. Suranova
Keyword(s):  
Respiratory Diseases ◽  
Respiratory Infections ◽  
Intracellular Bacteria ◽  
Acute Respiratory Infections ◽  
Pharmaceutical Therapy ◽  
Wide Range ◽  
Acute Respiratory Diseases ◽  
High Concentrations ◽  
Acute Respiratory Viral Infection ◽  
Social Importance

Acute respiratory diseases (ARD) are widespread diseases and are of great social importance. Diagnosis of acute respiratory infections implies the damage to the respiratory system caused by a wide range of pathogens. Among the pathogens of acute respiratory infections are viruses of acute respiratory viral infection (ARVI) group, including influenza, as well as fungal and bacterial pathogens, which include intracellular bacteria: mycoplasma and chlamydia. Diseases caused by intracellular pathogens are treated by antibacterial drugs that can easily penetrate the cells and create there high concentrations.

Sign in / Sign up

Export Citation Format

Share Document